CH691791A8 - Pharmazeutische komposition gegen alkoholmissbrauch und mit notroper wirkung. - Google Patents

Pharmazeutische komposition gegen alkoholmissbrauch und mit notroper wirkung. Download PDF

Info

Publication number
CH691791A8
CH691791A8 CH01664/96A CH166496A CH691791A8 CH 691791 A8 CH691791 A8 CH 691791A8 CH 01664/96 A CH01664/96 A CH 01664/96A CH 166496 A CH166496 A CH 166496A CH 691791 A8 CH691791 A8 CH 691791A8
Authority
CH
Switzerland
Prior art keywords
notroper
effect
pharmaceutical composition
composition against
against alcohol
Prior art date
Application number
CH01664/96A
Other languages
English (en)
Other versions
CH691791A5 (de
Inventor
Tatyana Dmitrievna Soldatenkova
Tatyana Tikhonovna Kondrashova
Julia Vasilievna Gudkova
Natalya Mikhailovna Burbenskaya
Irina Alexeevna Komissarova
Original Assignee
Tatyana Dmitrievna Soldatenkova
Tatyana Tikhonovna Kondrashova
Julia Vasilievna Gudkova
Natalya Mikhailovna Burbenskaya
Irina Alexeevna Komissarova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to RU9595100307A priority Critical patent/RU2097034C1/ru
Priority to US08/704,745 priority patent/US5798371A/en
Priority to PCT/RU1996/000006 priority patent/WO1996021446A1/ru
Priority to JP8521587A priority patent/JPH09510738A/ja
Priority to DE19626431A priority patent/DE19626431B4/de
Priority claimed from FR9608205A external-priority patent/FR2750605B1/fr
Application filed by Tatyana Dmitrievna Soldatenkova, Tatyana Tikhonovna Kondrashova, Julia Vasilievna Gudkova, Natalya Mikhailovna Burbenskaya, Irina Alexeevna Komissarova filed Critical Tatyana Dmitrievna Soldatenkova
Priority to CH01664/96A priority patent/CH691791A8/de
Publication of CH691791A5 publication Critical patent/CH691791A5/de
Publication of CH691791A8 publication Critical patent/CH691791A8/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CH01664/96A 1995-01-13 1996-07-03 Pharmazeutische komposition gegen alkoholmissbrauch und mit notroper wirkung. CH691791A8 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
RU9595100307A RU2097034C1 (ru) 1995-01-13 1995-01-13 Фармацевтический препарат антиалкогольного и ноотропного действия
US08/704,745 US5798371A (en) 1995-01-13 1996-01-04 Pharmaceutical composition endowed with an antialcoholic and nootropic effect
PCT/RU1996/000006 WO1996021446A1 (en) 1995-01-13 1996-01-04 Pharmaceutical composition with anti-alcoholic and nootropic properties
JP8521587A JPH09510738A (ja) 1995-01-13 1996-01-04 禁酒及びヌートロピック効果を付与された医薬組成物
DE19626431A DE19626431B4 (de) 1995-01-13 1996-07-01 Verwendung einer pharmazeutische Komposition mit antialkoholischer und nootroper Wirkung
CH01664/96A CH691791A8 (de) 1995-01-13 1996-07-03 Pharmazeutische komposition gegen alkoholmissbrauch und mit notroper wirkung.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
RU9595100307A RU2097034C1 (ru) 1995-01-13 1995-01-13 Фармацевтический препарат антиалкогольного и ноотропного действия
DE19626431A DE19626431B4 (de) 1995-01-13 1996-07-01 Verwendung einer pharmazeutische Komposition mit antialkoholischer und nootroper Wirkung
FR9608205A FR2750605B1 (fr) 1995-01-13 1996-07-02 Composition pharmaceutique a effets antialcooliques et nootropes
CH01664/96A CH691791A8 (de) 1995-01-13 1996-07-03 Pharmazeutische komposition gegen alkoholmissbrauch und mit notroper wirkung.

Publications (2)

Publication Number Publication Date
CH691791A5 CH691791A5 (de) 2001-10-31
CH691791A8 true CH691791A8 (de) 2002-03-15

Family

ID=27428256

Family Applications (1)

Application Number Title Priority Date Filing Date
CH01664/96A CH691791A8 (de) 1995-01-13 1996-07-03 Pharmazeutische komposition gegen alkoholmissbrauch und mit notroper wirkung.

Country Status (5)

Country Link
JP (1) JPH09510738A (de)
CH (1) CH691791A8 (de)
DE (1) DE19626431B4 (de)
RU (1) RU2097034C1 (de)
WO (1) WO1996021446A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2097034C1 (ru) * 1995-01-13 1997-11-27 Ирина Алексеевна Комиссарова Фармацевтический препарат антиалкогольного и ноотропного действия
FR2750605B1 (fr) * 1995-01-13 1998-09-25 Komissarova Irina Alexeevna Composition pharmaceutique a effets antialcooliques et nootropes
RU2145213C1 (ru) * 1999-05-25 2000-02-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция, обладающая ноотропным действием, и способ ее получения
RU2145855C1 (ru) * 1999-05-26 2000-02-27 Смирнов Леонид Дмитриевич Анксиолитическое, противоалкогольное, церебропротекторное лекарственное средство
RU2165759C1 (ru) * 2000-02-29 2001-04-27 Общество с ограниченной ответственностью "Бивитех" Средство для лечения алкогольной интоксикации
RU2177320C1 (ru) * 2000-12-21 2001-12-27 Попов Виктор Георгиевич Средство, ослабляющее выраженность постинтоксикационного алкогольного синдрома
RU2177783C1 (ru) * 2001-02-02 2002-01-10 Общество С Ограниченной Ответственностью "Консорциум-Пик" Ноотропное средство
RU2252023C2 (ru) * 2002-11-21 2005-05-20 Миронов Николай Владимирович Способ лечения черепно-мозговой травмы
RU2561063C1 (ru) * 2014-07-01 2015-08-20 Общество с ограниченной ответственностью "Научно-производственное объединение "Фарматрон" (НПО "Фарматрон") Способ коррекции неврологических нарушений при хронической алкогольной интоксикации
JP2018127427A (ja) * 2017-02-10 2018-08-16 味の素株式会社 唾液分泌促進剤、ならびにこれを配合した食品組成物、および口腔用組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405629A (en) * 1979-05-07 1983-09-20 Massachusetts Institute Of Technology Process for increasing glycine levels in the brain and spinal cord
US4761429A (en) * 1985-07-22 1988-08-02 Kenneth Blum Enkephalinase and endorphinase inhibitors as anti-craving compositions
US5019558A (en) * 1988-05-09 1991-05-28 Georges Cehovic Method for treating memory disturbances using arginine aspartate
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
JP3162709B2 (ja) * 1992-01-10 2001-05-08 アレクセエフナ コミッサロバ，イリナ 抗ストレス、ストレス予防性及び向神経性作用の医薬調製物
RU2097034C1 (ru) * 1995-01-13 1997-11-27 Ирина Алексеевна Комиссарова Фармацевтический препарат антиалкогольного и ноотропного действия

Also Published As

Publication number Publication date
WO1996021446A1 (en) 1996-07-18
DE19626431B4 (de) 2011-03-17
RU2097034C1 (ru) 1997-11-27
DE19626431A1 (de) 1998-01-08
JPH09510738A (ja) 1997-10-28
CH691791A5 (de) 2001-10-31

Similar Documents

Publication Publication Date Title
DE69600065D1 (de) Dermatologische und/oder pharmazeutische Zubereitung, ihre Herstellung und Anwendung
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
DE69525148D1 (de) Pharmazeutische formulierung
FI962589L (fi) 2,4-disulfofenyylibutyylinitroni, sen suolat ja niiden käyttö farmaseuttisina aineina
DE122005000024I1 (de) Darifenacin enthaltende Pharmazeutische Zubereitungen.
ATE188471T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
BR9506119A (pt) Composição farmacêutica e forma de dosagem farmacêutica unitária
BR9713237B1 (pt) comprimido de liberaÇço controlada de cloridrato de alfuzosina e composiÇço farmacÊutica compreendendo o mesmo.
PT861666E (pt) Composicao farmaceutica para utilizacao no tratamento da diabetes
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
DE69300913D1 (de) Polymorph Terazosin und pharmazeutische Zusammenstellung.
ATE288419T1 (de) Alpha-aryl-n-alkylnitrone sowie diese enthaltende pharmazeutische zubereitungen
FI955140A7 (fi) Uusia kinoksaliinidionijohdannaisia, niiden valmistus ja käyttö lääkke issä
DE59704397D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
DE59607535D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
BR9602915A (pt) Medicamentos uso e formulação farmacêutica
DE69704060D1 (de) Tetrahydroisochinolinderivate und ihre pharmazeutische anwendung
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
FI956273A7 (fi) Optisesti aktiivinen bentsotiepiinijohdannainen, sen valmistus ja käyttö
DE58905324D1 (de) Mittel gegen protozoen bei insekten.
DE69611082D1 (de) Bertholletia enthaltende kosmetische oder pharmazeutische,insbesondere dermatologische zusammensetzung
FI972988L (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
DE69614407D1 (de) Pharmazeutische zusammensetzungen
DE69434210D1 (de) Pharmazeutische antacidzusammensetzung

Legal Events

Date Code Title Description
PL Patent ceased
PK Correction

Free format text: INHABER UND ERFINDERNAMEN KORRIEGIERT.